The Hunger Hormone Ghrelin Drives Stress-Induced Fear Through a New Brain Pathway Linked to PTSD

The peptide hormone ghrelin drives stress-induced vulnerability to enhanced fear learning through a novel pathway independent of the classical HPA stress axis. Stress-related increases in circulating ghrelin are both necessary and sufficient for exacerbated fear learning, acting through ghrelin receptors in the amygdala. Ghrelin's fear-enhancing effects require growth hormone (GH) in the amygdala — GH was upregulated after chronic stress, its release was enhanced by ghrelin receptor stimulation, and blocking GH receptors prevented ghrelin's fear-enhancing effects. Critically, ghrelin receptor antagonism during stress blocked enhanced fear without affecting corticosterone levels, confirming this is a separate stress response pathway.

Researchers used a rodent PTSD model where rats repeatedly exposed to stressors develop heightened fear learning via auditory Pavlovian fear conditioning. They used systemic and intraamygdala ghrelin receptor agonist/antagonist administration, virus-mediated overexpression of GH and GH receptor antagonist in the amygdala, and measured circulating ghrelin, corticosterone, CRF, and amygdala GH protein levels.

PTSD and stress-related disorders have long been linked to the HPA axis (cortisol/corticosterone), but treatments targeting this system have had limited success. This study reveals ghrelin — a peptide better known for regulating hunger — as a mediator of a completely separate stress response branch that directly enhances fear memories in the brain's fear center. This opens new therapeutic targets for PTSD that don't involve the traditional stress hormone pathway.

This study fundamentally changes our understanding of the hormonal stress response by identifying ghrelin as a mediator of a second, independent stress pathway. It connects the metabolic and emotional stress responses through a peptide previously associated only with appetite. This discovery could explain why PTSD patients often have metabolic disturbances and opens the door to peptide-based therapies targeting the ghrelin-GH axis for stress disorders.

This is a rodent study, and the ghrelin-GH-fear pathway may not translate identically to humans. The PTSD model, while well-established, is a simplified representation of the complex human disorder. The study focused on fear learning rather than other PTSD features like avoidance or hyperarousal. Ghrelin manipulation could affect feeding behavior and metabolism, which may confound behavioral observations.